<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36999">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02141321</url>
  </required_header>
  <id_info>
    <org_study_id>9010023</org_study_id>
    <nct_id>NCT02141321</nct_id>
  </id_info>
  <brief_title>Sub Lingual Misoprostol Before IUD Insertion in Women With Only Previous Cesarean Section</brief_title>
  <official_title>SUB LINGUAL MISOPROSTOL PRIOR TO IUD INSERTION IN WOMEN WITH ONLY PREVIOUS CESARIAN SECTION: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <authority>Egypt: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the work is to evaluate the efficacy of the sub lingual prostaglandin E1
      synthetic analogue (misoprostol) before IUD insertion to facilitate the procedure in
      patients delivered before only by cesarean section.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be conducted at Ain Shams University Maternity Hospital. 124 women candidate
      for Cu T 380A IUD insertion will be enrolled in the study. Half of them will receive 400
      micro gram of misoprostol (Sigma) sub lingually and the other half will receive the placebo
      two hours before IUD insertion.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)</study_design>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>During the procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>The perception of pain and discomfort as described by the patient assessed by Visual Analogue Scale (VAS). The scale will be graded from 0 to 10, 0 representing no pain at all and 10 worst possible imaginable pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difficulty of Procedure</measure>
    <time_frame>During the procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>The degree of difficulty of the IUD insertion judged by the investigator as the resistance met at the internal cervical os. The procedure either graded as (easy), (moderate difficulty) or (difficult) or (failed insertion).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>During the procedure and the following 24 hours.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Uterine perforation, excessive bleeding, fever, IUD expulsion or any other unexpected complications will be assessed during the procedure and followed for the next 24 hours.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>IUD Insertion</condition>
  <arm_group>
    <arm_group_label>Misoprostol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women will receive two sub lingual tablets each containing 200 micro gram misoprostol (Misotac), receiving a total dose of 400 micro grams. Two hour later, Cu T 380A IUD (PREGNA) will be inserted.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Women will receive two sub lingual placebo tablets which will be similar in size, color, odor and shape to the misoprostol tablets. Two hour later, Cu T 380A IUD (PREGNA) will be inserted.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <arm_group_label>Misoprostol</arm_group_label>
    <other_name>Misotac</other_name>
    <other_name>Cytotec</other_name>
    <other_name>Misotec</other_name>
    <other_name>Prostaglandin E1 synthetic analogue</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal size uterus.

          -  Willing to participate.

          -  Candidate for IUD insertion.

          -  Delivered only by cesarean section.

          -  Last delivery is more than 40 days before participating in the study.

        Exclusion Criteria:

          -  Previous vaginal delivery

          -  Signs of genital infection.

          -  Menopause.

          -  Body mass index (BMI) &gt; 35 kg/m2.

          -  Contraindication to misoprostol.

          -  Copper allergy.

          -  Positive pregnancy test.

          -  Had a prior attempt for IUD insertion.

          -  Uterine anomalies.

          -  Uterine fibroid.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed S. Sweed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hassan A. Bayoumy, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Y. Mohamed, M.B., B.Ch.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed S. Sweed, MD</last_name>
    <phone>01001222047</phone>
    <phone_ext>+2</phone_ext>
    <email>drmsweed@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ain Shams University Maternity Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed S. Sweed, MD</last_name>
      <phone>01001222047</phone>
      <phone_ext>+2</phone_ext>
      <email>drmsweed@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mohamed S. Sweed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 16, 2014</lastchanged_date>
  <firstreceived_date>May 15, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mohamed S Sweed, MD</investigator_full_name>
    <investigator_title>Mohamed S. Sweed lecturer of Obstetrics &amp; Gynecology AinShams University.</investigator_title>
  </responsible_party>
  <keyword>IUD</keyword>
  <keyword>Misoprostol</keyword>
  <keyword>Rectal administration</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Alprostadil</mesh_term>
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
